Effects of transaldolase exchange on estimates of gluconeogenesis in type 2 diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 4, 2013, Pages

  Rajpal, Aman ^a   Dube, Simmi ^a   Carvalho, Filipa ^b   Simoes, Ana Rita ^b   Figueiredo, Angelo ^c   Basu, Ananda ^a   Jones, John ^b,d   Basu, Rita ^a  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d Portuguese Diabetes Association   (Portugal)

Author keywords

Deuterated water; Gluconeogenesis; Transaldolase; Triose phosphate isomerase

Indexed keywords

ACETIC ACID; GLUCOSE; GLYCEROL; INSULIN; TRANSALDOLASE; TRIOSEPHOSPHATE ISOMERASE;

ADULT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TURNOVER TIME;

DEUTERATED WATER; GLUCONEOGENESIS; TRANSALDOLASE; TRIOSE PHOSPHATE ISOMERASE;

ACETIC ACID; AGED; CARBON RADIOISOTOPES; DEUTERIUM OXIDE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCONEOGENESIS; GLUCOSE; GLYCEROL; HUMANS; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; ISOMERISM; KINETICS; MALE; MIDDLE AGED; TRANSALDOLASE; TRIOSE-PHOSPHATE ISOMERASE; TRITIUM;

EID: 84881655284     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00245.2013     Document Type: Article

References (29)

1. Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes 52: 2213-2220, 2003.
2. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk F, Rizza RA. Type 2 diabetes impairs sphlanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50: 1351-1362, 2001.
3. Basu R, Barosa C, Basu A, Pattan V, Saad A, Jones J, Rizza R. Transaldolase exchange and its effects on measurements of gluconeogenesis in humans. Am J Physiol Endocrinol Metab 300: E296-E303, 2011.
4. Basu R, Barosa C, Jones J, Dube S, Carter R, Basu A, Rizza RA. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia. J Clin Endocrinol Metab 98: E409-E417, 2013.
5. Basu R, Basu A, Johnson CM, Schwenk WF, Rizza RA. Insulin doseresponse curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes 53: 2042-2050, 2004.
6. Basu R, Chandramouli V, Dicke B, Landau B, Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54: 1942-1948, 2005.
7. Basu R, Chandramouli V, Schumann W, Basu A, Landau BR, Rizza RA. Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes. Diabetes 58: 1539-1543, 2009.
8. Basu R, Schwenk WF, Rizza RA. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab 287: E55-E62, 2004.
9. 2O to measure gluconeogenesis in humans. Diabetes 57: 50-55, 2008.
10. Boden G, Chen X, Capulong E, Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50: 810-816, 2001.
11. Boden G, Chen X, Stein TP. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280: E23-E30, 2001.
12. 2O for estimating rates of gluconeogenesis: determination and correction of error due to transaldolase exchange. Am J Physiol Endocrinol Metab 303: E1304-E1312, 2012.
13. Chen X, Iqbal N, Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999.
14. Diraison F, Large V, Brunengraber H, Beylot M. Gluconeogenesis is not increased in mildly hyperglycemic non-insulin-dependent diabetic patients (Abstract). Diabetologia 40: 955, 1997.
15. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR, Ferrannini E. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49: 1367-1373, 2000.
16. Gastaldelli A, Miyazaki Y, Pettiti M, Buzzigoli E, Mahankali S, Ferrannini E, DeFronzo RA. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J Clin Endocrinol Metab 89: 3914-3921, 2004.
17. Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 50: 1807-1812, 2001.
18. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, Shulman GI. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49: 2063-2069, 2000.
19. 13C-enrichment of human glucuronide from metabolic tracers. J Carb Chem 25: 203-217, 2006.
20. Jones JG, Fagulha A, Barosa C, Bastos M, Baptista C, Caldeira MM, Carvalheiro M. Noninasive analysis of hepatic glycogen kinetics before and after brakfast with deuterated water and acetaminophen. Diabetes 55: 2294-2300, 2006.
21. Jones JG, Garcia P, Barosa C, Delgado TC, Caldeira MM, Diogo L. Quantification of hepatic transaldolase exchange activity and its effects on tracer measurements of indirect pathway flux in humans. Magn Reson Med 59: 423-429, 2008.
22. 13C NMR study of gluconeogenesis and TCA cycle flux in humans. Am J Physiol Endocrinol Metab 281: E848-E856, 2001.
23. Kacerovsky M, Jones J, Schmid AI, Barosa C, Lettner A, Kacerovsky-Bielesz G, Szendroedi J, Chmelik M, Nowotny P, Chandramouli V, Wolzt M, Roden M. Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. Diabetes 60: 1752-1758, 2011.
24. 2H nuclear magnetic resonance spectroscopy. Diabetes 52: 2475-2482, 2003.
25. Magnusson I, Schumann WC, Bartsch GE, Chandramouli V, Kumaran K, Wahren J, Landau BR. Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem 266: 6975-6984, 1991.
26. Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhäusl W, Shulman GI. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49: 701-707, 2000.
27. Steele R, Wall J, DeBodo R, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
28. Wajngot A, Chandramouli V, Schumann WC, Ekberg K, Jones PK, Efendic S, Landau BR. Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 50: 47-52, 2001.
29. Weis BC, Margolis D, Burgess SC, Merritt ME, Wise H, Sherry AD, Malloy CR. Glucose production pathways by 2H and 13C NMR in patients with HIV-associated lipoatrophy. Magn Reson Med 51: 649-654, 2004.